TY - JOUR
T1 - Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus–positive oropharyngeal squamous cell carcinoma
AU - Haft, Sunny
AU - Ren, Shuling
AU - Xu, Guorong
AU - Mark, Adam
AU - Fisch, Kathleen
AU - Guo, Theresa W.
AU - Khan, Zubair
AU - Pang, John
AU - Ando, Mizuo
AU - Liu, Chao
AU - Sakai, Akihiro
AU - Fukusumi, Takahito
AU - Califano, Joseph A.
N1 - Funding Information:
This publication was supported by the National Institutes of Health (R01 DE023347 to Joseph A. Califano and Shuling Ren).
Publisher Copyright:
© 2019 American Cancer Society
PY - 2019/7/15
Y1 - 2019/7/15
N2 - Background: Human papillomavirus (HPV)–associated oropharyngeal cancer is a disease clinically and biologically distinct from smoking-related head and neck squamous cell carcinoma (HNSCC). Despite its rapidly increasing incidence, the mutational landscape of HPV+ oropharyngeal squamous cell carcinoma (OPSCC) remains understudied. Methods: This article presents the first mutational analysis of the 46 HPV+ OPSCC tumors within the newly expanded cohort of 530 HNSCC tumors from The Cancer Genome Atlas. A separate exome sequencing analysis was also performed for 46 HPV+ OPSCCs matched to their normal lymphocyte controls from the Johns Hopkins University cohort. Results: There was a strikingly high 33% frequency of mutations within genes associated with chromatin regulation, including mutations in lysine methyltransferase 2C (KMT2C), lysine methyltransferase 2D (KMT2D), nuclear receptor binding SET domain protein 1 (NSD1), CREB binding protein (CREBBP), E1A-associated protein p300 (EP300), and CCCTC-binding factor (CTCF). In addition, the commonly altered genes phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA) and fibroblast growth factor receptor 3 (FGFR3) showed distinct domain-specific hotspot mutations in comparison with their HPV– counterparts. PIK3CA showed a uniquely high rate of mutations within the helicase domain, and FGFR3 contained a predominance of hotspot S249C alterations that were not found in HPV– HNSCC. Conclusions: This analysis represents one of the largest studies to date of HPV+ OPSCC and lends novel insight into the genetic landscape of this biologically distinct disease, including a high rate of mutations in histone- and chromatin-modifying genes, which may offer novel therapeutic targets.
AB - Background: Human papillomavirus (HPV)–associated oropharyngeal cancer is a disease clinically and biologically distinct from smoking-related head and neck squamous cell carcinoma (HNSCC). Despite its rapidly increasing incidence, the mutational landscape of HPV+ oropharyngeal squamous cell carcinoma (OPSCC) remains understudied. Methods: This article presents the first mutational analysis of the 46 HPV+ OPSCC tumors within the newly expanded cohort of 530 HNSCC tumors from The Cancer Genome Atlas. A separate exome sequencing analysis was also performed for 46 HPV+ OPSCCs matched to their normal lymphocyte controls from the Johns Hopkins University cohort. Results: There was a strikingly high 33% frequency of mutations within genes associated with chromatin regulation, including mutations in lysine methyltransferase 2C (KMT2C), lysine methyltransferase 2D (KMT2D), nuclear receptor binding SET domain protein 1 (NSD1), CREB binding protein (CREBBP), E1A-associated protein p300 (EP300), and CCCTC-binding factor (CTCF). In addition, the commonly altered genes phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit α (PIK3CA) and fibroblast growth factor receptor 3 (FGFR3) showed distinct domain-specific hotspot mutations in comparison with their HPV– counterparts. PIK3CA showed a uniquely high rate of mutations within the helicase domain, and FGFR3 contained a predominance of hotspot S249C alterations that were not found in HPV– HNSCC. Conclusions: This analysis represents one of the largest studies to date of HPV+ OPSCC and lends novel insight into the genetic landscape of this biologically distinct disease, including a high rate of mutations in histone- and chromatin-modifying genes, which may offer novel therapeutic targets.
KW - The Cancer Genome Atlas (TCGA)
KW - epigenetics
KW - exome sequencing
KW - head and neck squamous cell carcinoma
KW - human papillomavirus (HPV)
KW - oropharyngeal squamous cell carcinoma
UR - http://www.scopus.com/inward/record.url?scp=85063794219&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063794219&partnerID=8YFLogxK
U2 - 10.1002/cncr.32068
DO - 10.1002/cncr.32068
M3 - Article
C2 - 30933315
AN - SCOPUS:85063794219
SN - 0008-543X
VL - 125
SP - 2423
EP - 2434
JO - Cancer
JF - Cancer
IS - 14
ER -